(Hypertension. 1997;30:725.)
© 1997 American Heart Association, Inc.
Articles |
From the Departments of Medicine and Pathology, University of Virginia Health Sciences Center (Charlottesville); and the Department of Pharmacology and Therapeutics, University College Cork, Ireland (D.P.OC.).
Correspondence to Robert M. Carey, MD, Box 395, University of Virginia Health Sciences Center, Charlottesville, Va 22908. E-mail RMC4C{at}virginia.edu
Abstract The dopamine D1 receptor has recently been identified in the rat heart and kidney. In the present study, using Western blot analysis and light microscopic immunohistochemistry, we examined D1 receptor protein expression in the human kidney and heart. Antipeptide polyclonal rabbit antiserum was raised against the third extracellular domain of the native receptor and affinity-purified using a protein-A column. Selectivity of the antiserum was validated by recognition of the D1 receptor expressed in stably transfected LTK- cells and Sf-9 cells. The immunohistochemical staining for D1 receptor protein was distributed throughout the atrium and ventricular myocardium and in the coronary vessels. In the kidney, positive immunoreactive signal was detected in the proximal and distal tubules, the collecting ducts, and the large intrarenal vasculature, whereas staining was absent in the juxtaglomerular (JG) cells and the glomeruli. D1 receptor antiserum preadsorbed against the immunizing peptide did not produce significant staining. In Western blot analysis, a single 55-kD band was detected for the D1 receptor in membranes from the D1 receptor transfected Sf-9 cells but not in nontransfected cells. In the heart and kidney, we detected a 55-kD band as well as an additional 40-kD band, which may reflect partial degradation of the receptor protein. These results provide the first evidence for the localization of the dopamine D1 receptor protein in the human heart and kidney. The similar distribution of this subtype receptor in the human heart and kidney to that in the rat supports the possible (patho)physiological significance of the peripheral dopamine system in humans.
Key Words: immunohistochemistry dopamine receptors heart kidney human
This article has been cited by other articles:
![]() |
Z. Li, C. Yu, Y. Han, H. Ren, W. Shi, C. Fu, D. He, L. Huang, C. Yang, X. Wang, et al. Inhibitory effect of D1-like and D3 dopamine receptors on norepinephrine-induced proliferation in vascular smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2761 - H2768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Staessen, T. Kuznetsova, H. Zhang, M. Maillard, M. Bochud, S. Hasenkamp, J. Westerkamp, T. Richart, L. Thijs, X. Li, et al. Blood Pressure and Renal Sodium Handling in Relation to Genetic Variation in the DRD1 Promoter and GRK4 Hypertension, June 1, 2008; 51(6): 1643 - 1650. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ding, R. F. Wiegerinck, M. Shen, A. Cojoc, C. M. Zeidenweber, and M. B. Wagner Dopamine increases L-type calcium current more in newborn than adult rabbit cardiomyocytes via D1 and {beta}2 receptors Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2327 - H2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zeng, H. Sanada, H. Watanabe, G. M. Eisner, R. A. Felder, and P. A. Jose Functional genomics of the dopaminergic system in hypertension Physiol Genomics, November 17, 2004; 19(3): 233 - 246. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Flynn, D. Winters, P. Breen, G. O'Sullivan, G. Shorten, D. O'Connell, A. O'Donnell, and T. Aherne Dopexamine increases internal mammary artery blood flow following coronary artery bypass grafting Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 547 - 551. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Carey Renal Dopamine System: Paracrine Regulator of Sodium Homeostasis and Blood Pressure Hypertension, September 1, 2001; 38(3): 297 - 302. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Feraille and A. Doucet Sodium-Potassium-Adenosinetriphosphatase-Dependent Sodium Transport in the Kidney: Hormonal Control Physiol Rev, January 1, 2001; 81(1): 345 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sanada, P. A. Jose, D. Hazen-Martin, P.-Y. Yu, J. Xu, D. E. Bruns, J. Phipps, R. M. Carey, and R. A. Felder Dopamine-1 Receptor Coupling Defect in Renal Proximal Tubule Cells in Hypertension Hypertension, April 1, 1999; 33(4): 1036 - 1042. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Wang, A. F. Moore, R. Ozono, H. M. Siragy, and R. M. Carey Immunolocalization of Subtype 2 Angiotensin II (AT2) Receptor Protein in Rat Heart Hypertension, July 1, 1998; 32(1): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Brismar, M. Asghar, R. M. Carey, P. Greengard, and A. Aperia Dopamine-induced recruitment of dopamine D1 receptors to the plasma membrane PNAS, May 12, 1998; 95(10): 5573 - 5578. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |